Munich - Delayed Quote EUR

IGM Biosciences Inc (1K0.MU)

Compare
4.8000
-1.3000
(-21.31%)
At close: January 10 at 9:07:09 AM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,918.0000
2,130.0000
1,069.0000
--
--
Operating Expense
237,637.0000
265,591.0000
229,025.0000
165,323.0000
83,280.0000
Operating Income
-234,719.0000
-263,461.0000
-227,956.0000
-165,323.0000
-83,280.0000
Net Non Operating Interest Income Expense
15,118.0000
17,743.0000
7,035.0000
159.0000
1,925.0000
Other Income Expense
--
-20.0000
-181.0000
159.0000
1,925.0000
Pretax Income
-219,601.0000
-245,738.0000
-221,102.0000
-165,164.0000
-81,355.0000
Tax Provision
242.0000
678.0000
--
--
--
Net Income Common Stockholders
-219,843.0000
-246,416.0000
-221,102.0000
-165,164.0000
-81,355.0000
Diluted NI Available to Com Stockholders
-219,843.0000
-246,416.0000
-221,102.0000
-165,164.0000
-81,355.0000
Basic EPS
-3.61
-4.71
-5.32
-4.93
-2.65
Diluted EPS
-3.61
-4.71
-5.32
-4.93
-2.65
Basic Average Shares
60,280.2130
52,311.9580
41,543.9540
33,479.7820
30,748.2800
Diluted Average Shares
60,280.2130
52,311.9580
41,543.9540
33,479.7820
30,748.2800
Total Operating Income as Reported
-234,719.0000
-263,461.0000
-227,956.0000
-165,323.0000
-83,280.0000
Total Expenses
237,637.0000
265,591.0000
229,025.0000
165,323.0000
83,280.0000
Net Income from Continuing & Discontinued Operation
-219,843.0000
-246,416.0000
-221,102.0000
-165,164.0000
-81,355.0000
Normalized Income
-219,843.0000
-246,416.0000
-221,102.0000
-165,164.0000
-81,355.0000
Interest Income
15,118.0000
17,743.0000
7,035.0000
159.0000
1,925.0000
Net Interest Income
15,118.0000
17,743.0000
7,035.0000
159.0000
1,925.0000
EBIT
-234,719.0000
-263,461.0000
-227,956.0000
-165,323.0000
-83,280.0000
EBITDA
-225,779.0000
-255,184.0000
-221,881.0000
-160,839.0000
-82,255.0000
Reconciled Depreciation
8,940.0000
8,277.0000
6,075.0000
4,484.0000
1,025.0000
Net Income from Continuing Operation Net Minority Interest
-219,843.0000
-246,416.0000
-221,102.0000
-165,164.0000
-81,355.0000
Normalized EBITDA
-225,779.0000
-255,184.0000
-221,881.0000
-160,839.0000
-82,255.0000
Tax Rate for Calcs
0.0002
0.0002
--
--
--
12/31/2020 - 9/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LSRM.MU CEL-SCI Corp
0.3628
-0.38%
 
LSRM.SG CEL-SCI Corp
0.3992
+13.67%
 
LSRM.F CEL-SCI Corporation
0.3478
-0.11%
 
LSRM.BE CEL-SCI Corp
0.3470
+0.17%
 
LSRM.DU CEL-SCI Corp
0.3846
+9.57%
 
NFX.L Nuformix plc
0.0600
+26.32%
 
OBD.L Oxford BioDynamics Plc
0.9110
-8.90%
 
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
 
TCBPW TC Biopharm (Holdings) Plc
0.0150
+19.05%
 
IPH.PA Innate Pharma S.A.
1.8080
+2.15%